What the business is
Oura makes a smart ring that tracks sleep and health biometrics, sold with AI-powered membership features.
The bet
That public-market investors would price it as an AI-enabled digital-health platform rather than a consumer hardware maker — and it postponed rather than accept less.
Starting capital
Proposed terms: 50M shares at $40–44; about $2.1B gross at the $42 midpoint — roughly $567M of new money for Oura, about $1.53B for selling shareholders.
How it started
After a much-anticipated roadshow, Oura set terms of 50 million shares at $40–44 apiece; at the $42 midpoint the deal would raise about $2.1B gross, with a fully diluted valuation of $15.6B at the top end.
What happened
Two problems surfaced. Valuation: that price only works if investors see an AI-enabled digital-health platform — 'if you are just looking at them as a pure ring manufacturer, just consumer hardware, then that valuation is pretty hefty,' said IPOX vice president Kat Siu, and Oura's sales still lean heavily toward hardware. Structure: only 13.5 million of the 50 million shares (27%) were to be newly issued; the other 36.5 million (73%) were selling shareholders — about $1.53B to insiders versus roughly $567M to the company at the midpoint.
How it ended up
On September 29, 2026, CEO Tom Hale postponed the offering, citing 'uncertainty in the IPO market,' with no new date given.
What has to be true
The postponement is the moment the platform-versus-hardware valuation question stopped being a narrative and started having a price.
The structure told on the motive: 73% secondary selling read as an insider liquidity event, a hard sell in a fragile IPO market.
Postponing rather than repricing preserved the platform story — but left Oura private while giants like Apple press on wearables.
What can be applied
When 73% of an IPO is insiders selling, the market reads it as a liquidity event, not a growth raise — and a platform valuation collapses if buyers price the hardware.
Aftermath
As of 2026-10-07 Oura remains private. The company characterizes the move as 'postponing' the offering, with no indication of when it might return; Fortune's Term Sheet editor expects it could try again, and describes an IPO market in 'suspended animation.'
FOLLOW THE EVIDENCE
The sources
- Why Oura delayed its IPO fortune.com